Xiangjun Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiangjun Li has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Haiyang Li
Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Hebei Medical University, Hebei Technology Innovation Center of Oral Health, Hebei Key Laboratory of Stomatology and Clinical Research Centre for Oral Diseases
9 shared publicationsXiaoyan Zhang
Department of Oral and Maxillofacial Surgery, School of Stomatology, Hebei Medical University, Hebei Technology Innovation Center of Oral Health, Key Laboratory of Stomatology and Clinical Research Centre for Oral Diseases, Shijiazhuang, China
8 shared publicationsTiepeng Xiao
Department of Orthodontics, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China
7 shared publicationsShuai Guan
Department of Oral and Maxillofacial Surgery, School of Stomatology, Hebei Medical University, Hebei Technology Innovation Center of Oral Health, Key Laboratory of Stomatology and Clinical Research Centre for Oral Diseases, Hebei Province, Shijiazhuang, 050017, China
6 shared publicationsXiao Zhang
Department of Oral and Maxillofacial Surgery, School of Stomatology, Hebei Medical University, Hebei Technology Innovation Center of Oral Health, Key Laboratory of Stomatology and Clinical Research Centre for Oral Diseases, Hebei Province, Shijiazhuang, 050017, China
6 shared publicationsXingyue Ma
Department of Oral and Maxillofacial Surgery, School of Stomatology, Hebei Medical University, Hebei Technology Innovation Center of Oral Health, Key Laboratory of Stomatology and Clinical Research Centre for Oral Diseases, Shijiazhuang, China
5 shared publications
Latest Publications
- Open Access
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1770116
Spatial transcriptomics uncovers TAC-OGEs heterogeneity and FN1/MMP9 signature in ameloblastoma
Objective: This study aims to explore how the tumour microenvironment influences the aggressiveness, malignancy, and recurrence of ameloblastoma. By employing a spatial omics approach, we will examine the characteristics of the invasive front of ameloblastoma. Methods: We systematically characterised the cellular heterogeneity of ameloblastoma using spatial transcriptomic sequencing combined with integrated omics analysis of clinical tumour specimens. Additionally, we independently validated the spatial expression patterns and levels of FN1 and MMP9 in ameloblastoma through immunohistochemistry in an independent case series of 15 specimens, further supported by single-cell resolution multiplex immunofluorescence. Results: Spatial transcriptomic sequencing delineated the ameloblastoma tumour ecosystem into seven primary cell clusters: epithelial tumour cells, fibroblasts, myeloid cells, endothelial cells, T cells, B cells, and Tumour-associated cells with osteoclast-like gene expression (TAC-OGEs). Significantly, cell clusters located at the tumour’s invasive front demonstrated notably increased expression of FN1 and MMP9. A more detailed analysis within the TAC-OGE compartment identified seven phenotypically distinct subclusters. Interestingly, their differentiation states formed a spatial gradient, extending from the tumour core to the periphery. This spatial expression pattern of FN1 and MMP9 was confirmed through immunohistochemical staining at the tumour-stroma interface. Conclusion: Our findings collectively reveal the cellular heterogeneity of ameloblastoma and highlight tumour-margin-associated TAC-OGEs as potential spatially associated components of local invasion. These results suggest that targeting TAC-OGE-associated processes may represent a potential therapeutic strategy in the management of ameloblastoma.
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1770116
Open AccessSpatial transcriptomics uncovers TAC-OGEs heterogeneity and FN1/MMP9 signature in ameloblastoma
Objective: This study aims to explore how the tumour microenvironment influences the aggressiveness, malignancy, and recurrence of ameloblastoma. By employing a spatial omics approach, we will examine the characteristics of the invasive front of ameloblastoma. Methods: We systematically characterised the cellular heterogeneity of ameloblastoma using spatial transcriptomic sequencing combined with integrated omics analysis of clinical tumour specimens. Additionally, we independently validated the spatial expression patterns and levels of FN1 and MMP9 in ameloblastoma through immunohistochemistry in an independent case series of 15 specimens, further supported by single-cell resolution multiplex immunofluorescence. Results: Spatial transcriptomic sequencing delineated the ameloblastoma tumour ecosystem into seven primary cell clusters: epithelial tumour cells, fibroblasts, myeloid cells, endothelial cells, T cells, B cells, and Tumour-associated cells with osteoclast-like gene expression (TAC-OGEs). Significantly, cell clusters located at the tumour’s invasive front demonstrated notably increased expression of FN1 and MMP9. A more detailed analysis within the TAC-OGE compartment identified seven phenotypically distinct subclusters. Interestingly, their differentiation states formed a spatial gradient, extending from the tumour core to the periphery. This spatial expression pattern of FN1 and MMP9 was confirmed through immunohistochemical staining at the tumour-stroma interface. Conclusion: Our findings collectively reveal the cellular heterogeneity of ameloblastoma and highlight tumour-margin-associated TAC-OGEs as potential spatially associated components of local invasion. These results suggest that targeting TAC-OGE-associated processes may represent a potential therapeutic strategy in the management of ameloblastoma.
- Open Access
- 19 March 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
ZIC2 affects oral squamous cell carcinoma stemness by regulating glycerophosphocholine metabolism via LYPLA2
Oral squamous cell carcinoma (OSCC) is a common malignant tumor of the head and neck. Early-stage OSCC is primarily treated using surgery; advanced-stage OSCC is managed using a multidisciplinary approach, including surgery combined with adjuvant radiotherapy and chemotherapy. However, tumor recurrence and metastasis remain major challenges, with a 5-year survival rate of ~50%. Dysregulation of transcription factors is associated with the pathogenesis of various cancers. This study focused on the role of ZIC2, a member of the zinc finger protein family, in OSCC. ZIC2 was identified as a prognostically relevant transcription factor in OSCC through bioinformatic analysis, showing high expression in OSCC and association with poor prognosis in patients. In vitro and in vivo, ZIC2 knockdown inhibited the proliferation, migration, invasion, and spheroid formation ability of OSCC cells and restored their sensitivity to chemotherapeutic drugs; overexpression of ZIC2 showed the opposite effect. RNA-seq and targeted metabolomics analyses revealed that in OSCC cells with zic2 knockdown, the expression of glycerophosphocholine (GPC) and the key rate-limiting enzyme LYPLA2 was decreased. LYPLA2 overexpression rescued the effects of ZIC2 knockdown on the proliferation, migration, and invasion of OSCC cells. GPC increased the stemness of OSCC tumor cells; ZIC2-regulated GPC metabolism through LYPLA2, inducing changes in the expression of the cancer stem cell markers Nanog and OCT4. In conclusion, we identified ZIC2 as an OSCC stemness-related gene, a potential therapeutic target for OSCC, providing new insights for treating OSCC.
- 19 March 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessZIC2 affects oral squamous cell carcinoma stemness by regulating glycerophosphocholine metabolism via LYPLA2
Oral squamous cell carcinoma (OSCC) is a common malignant tumor of the head and neck. Early-stage OSCC is primarily treated using surgery; advanced-stage OSCC is managed using a multidisciplinary approach, including surgery combined with adjuvant radiotherapy and chemotherapy. However, tumor recurrence and metastasis remain major challenges, with a 5-year survival rate of ~50%. Dysregulation of transcription factors is associated with the pathogenesis of various cancers. This study focused on the role of ZIC2, a member of the zinc finger protein family, in OSCC. ZIC2 was identified as a prognostically relevant transcription factor in OSCC through bioinformatic analysis, showing high expression in OSCC and association with poor prognosis in patients. In vitro and in vivo, ZIC2 knockdown inhibited the proliferation, migration, invasion, and spheroid formation ability of OSCC cells and restored their sensitivity to chemotherapeutic drugs; overexpression of ZIC2 showed the opposite effect. RNA-seq and targeted metabolomics analyses revealed that in OSCC cells with zic2 knockdown, the expression of glycerophosphocholine (GPC) and the key rate-limiting enzyme LYPLA2 was decreased. LYPLA2 overexpression rescued the effects of ZIC2 knockdown on the proliferation, migration, and invasion of OSCC cells. GPC increased the stemness of OSCC tumor cells; ZIC2-regulated GPC metabolism through LYPLA2, inducing changes in the expression of the cancer stem cell markers Nanog and OCT4. In conclusion, we identified ZIC2 as an OSCC stemness-related gene, a potential therapeutic target for OSCC, providing new insights for treating OSCC.
- Open Access
- 1 December 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Saliva from oral squamous cell carcinoma patients promotes tumor progression via Inflammation, stromal remodeling, and metabolic reprogramming in a mouse model
Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive malignancy with increasing evidence implicating the oral microbiome and tumor microenviro
- 1 December 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Open AccessSaliva from oral squamous cell carcinoma patients promotes tumor progression via Inflammation, stromal remodeling, and metabolic reprogramming in a mouse model
Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive malignancy with increasing evidence implicating the oral microbiome and tumor microenviro
- Open Access
- 1 January 2025
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (1) , 214-226
Knockdown of HOXD13 in Oral Squamous Cell Carcinoma Inhibited its Proliferation, Migration, and Influenced Fatty Acid Metabolism
Background: HOXD13, a member of the homeobox gene family, plays a critical role in developmental processes and has been implicated in various malignancies, including pancreatic cancer and glioma. However, its role in oral squamous cell carcinoma (OSCC) remains poorly understood. This study aimed to elucidate the potential of HOXD13 as a diagnostic biomarker and therapeutic target for OSCC.
- 1 January 2025
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (1) , 214-226
Open AccessKnockdown of HOXD13 in Oral Squamous Cell Carcinoma Inhibited its Proliferation, Migration, and Influenced Fatty Acid Metabolism
Background: HOXD13, a member of the homeobox gene family, plays a critical role in developmental processes and has been implicated in various malignancies, including pancreatic cancer and glioma. However, its role in oral squamous cell carcinoma (OSCC) remains poorly understood. This study aimed to elucidate the potential of HOXD13 as a diagnostic biomarker and therapeutic target for OSCC.
- 12 December 2024
- Published by Elsevier in Cytotherapy
- Vol. 27 (4) , 483-492
“Combined synergistic effects of concentrated growth factors and adipose-derived mesenchymal stem cells on regeneration of induced mandibular defects in rabbits”
- 12 December 2024
- Published by Elsevier in Cytotherapy
- Vol. 27 (4) , 483-492
“Combined synergistic effects of concentrated growth factors and adipose-derived mesenchymal stem cells on regeneration of induced mandibular defects in rabbits”
- Open Access
- 31 May 2024
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 52 (5)
Isolated fracture of the coronoid process following a molar extraction: A rare case report
Isolated coronoid process fractures are uncommon, and iatrogenic isolated fractures are extremely rare. This case describes a displaced fracture of an isolated coronoid process thought to be due to excessive force applied by a dentist that had been overlooked and left untreated for about a month. The patient was a woman in her late 50’s and she had undergone a molar extraction. Her dentist had confused her symptoms of trismus, pain, and facial oedema with the complex tooth extraction procedure. Following a cone-beam computed tomography (CBCT) scan we showed that the mandibular coronoid process on her right side had suffered a longitudinal fracture, and the fractured fragment had rotated upwards and inwards. Following successful surgical elimination of the fragmented coronoid process, the patient received targeted physiotherapy sessions that yielded excellent results. At the five-month follow-up, the ability of the patient to open her mouth had improved enormously, and her facial appearance almost recovered to its original state.
- 31 May 2024
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 52 (5)
Open AccessIsolated fracture of the coronoid process following a molar extraction: A rare case report
Isolated coronoid process fractures are uncommon, and iatrogenic isolated fractures are extremely rare. This case describes a displaced fracture of an isolated coronoid process thought to be due to excessive force applied by a dentist that had been overlooked and left untreated for about a month. The patient was a woman in her late 50’s and she had undergone a molar extraction. Her dentist had confused her symptoms of trismus, pain, and facial oedema with the complex tooth extraction procedure. Following a cone-beam computed tomography (CBCT) scan we showed that the mandibular coronoid process on her right side had suffered a longitudinal fracture, and the fractured fragment had rotated upwards and inwards. Following successful surgical elimination of the fragmented coronoid process, the patient received targeted physiotherapy sessions that yielded excellent results. At the five-month follow-up, the ability of the patient to open her mouth had improved enormously, and her facial appearance almost recovered to its original state.
- Open Access
- 21 April 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (6) , 108340
Application value of a hybrid tracer during sentinel lymph node biopsy for head and neck malignancies: A systematic review and meta-analysis
- 21 April 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (6) , 108340
Open AccessApplication value of a hybrid tracer during sentinel lymph node biopsy for head and neck malignancies: A systematic review and meta-analysis
- Open Access
- 11 March 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 24 (2) , 262-291
Prognostic significance and immunological role of HPRT1 in human cancers
Hypoxanthine phosphoribosyl transferase 1 (HPRT1), once considered a housekeeping gene, has been identified as playing an important role in several tumors. Its role in pan-cancer, however, has not been systematically studied. This study evaluates the relationship between HPRT1 and clinical parameters, survival prognosis, and tumor immunity based on multi omics data from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. Drug sensitivity analysis screened 16 effective drugs against HPRT1, exploring the interactions with chemicals and genes. The significance of HPRT1 in tumor immunotherapy has also been investigated. Immunohistochemistry confirmed significant differences in the expression of HPRT1 between five tumor types (colon adenocarcinoma [COAD], head-neck squamous cell carcinoma [HNSC], lung adenocarcinoma [LUAD], thyroid carcinoma [THCA], and uterine corpus endometrial carcinoma [UCEC]) and adjacent normal tissues (P < 0.05). HPRT1 competitive endogenous RNA network was constructed in HNSC. Through cytological experiments, it was verified that HPRT1 plays a carcinogenic role in HNSC and is associated with tumor cell proliferation, migration, invasion, and apoptosis. In addition, there was a significant positive correlation between HPRT1 and programmed cell death-1 (PD-1) expression in HNSC (P < 0.05). These findings suggest that HPRT1 may be a potential biomarker for predicting and treating cancer.
- 11 March 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 24 (2) , 262-291
Open AccessPrognostic significance and immunological role of HPRT1 in human cancers
Hypoxanthine phosphoribosyl transferase 1 (HPRT1), once considered a housekeeping gene, has been identified as playing an important role in several tumors. Its role in pan-cancer, however, has not been systematically studied. This study evaluates the relationship between HPRT1 and clinical parameters, survival prognosis, and tumor immunity based on multi omics data from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. Drug sensitivity analysis screened 16 effective drugs against HPRT1, exploring the interactions with chemicals and genes. The significance of HPRT1 in tumor immunotherapy has also been investigated. Immunohistochemistry confirmed significant differences in the expression of HPRT1 between five tumor types (colon adenocarcinoma [COAD], head-neck squamous cell carcinoma [HNSC], lung adenocarcinoma [LUAD], thyroid carcinoma [THCA], and uterine corpus endometrial carcinoma [UCEC]) and adjacent normal tissues (P < 0.05). HPRT1 competitive endogenous RNA network was constructed in HNSC. Through cytological experiments, it was verified that HPRT1 plays a carcinogenic role in HNSC and is associated with tumor cell proliferation, migration, invasion, and apoptosis. In addition, there was a significant positive correlation between HPRT1 and programmed cell death-1 (PD-1) expression in HNSC (P < 0.05). These findings suggest that HPRT1 may be a potential biomarker for predicting and treating cancer.
- 19 September 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (18) , 16717-16727
Identification of ferroptosis-related proteins in ameloblastoma based on proteomics analysis
Purpose We used proteomic sequencing and experimental verification to identify the potential ferroptosis-related proteins in ameloblastoma. Methods Samples of ameloblastoma (n = 14) and normal gingival tissues (n = 5) were collected for proteomic sequencing to identify differentially expressed proteins (DEPs) in ameloblastoma. Ferroptosis-related genes were downloaded from FerrDb V2, which were then compared with DEPs to obtain ferroptosis-related DEPs (FR-DEPs). A functional enrichment analysis was performed, and a protein–protein interaction network was built. The hub proteins were screened using the Cytoscape software, and potential drugs targeting them were retrieved from the DrugBank database. A hub protein was selected for immunohistochemical validation, and its expression was assessed in ameloblastomas, odontogenic keratocysts, dentigerous cysts, and normal gingival tissues. The primary ameloblastoma cells were cultured to explore the effect of the protein on the migratory properties of the tumour cells. Results A total of 58 FR-DEPs were screened, and six hub proteins were identified: mTOR, NFE2L2, PRKCA, STAT3, EGFR, and CDH1. Immunohistochemical analysis showed that mTOR expression was upregulated in ameloblastomas compared with that in odontogenic keratocysts, dentigerous cysts, and normal gingival tissues. p-mTOR was highly expressed in ameloblastomas, with a positivity rate of 83.3%. In addition, rapamycin, an inhibitor of mTOR, can inhibit the migratory capacity of primary cultured ameloblastoma cells. Conclusion Our results revealed the ferroptosis-related proteins in ameloblastomas and their underlying biological processes. Additionally, mTOR was overexpressed and was found to be associated with the aggressiveness of ameloblastomas, which may be a potential target for future treatments.
- 19 September 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (18) , 16717-16727
Identification of ferroptosis-related proteins in ameloblastoma based on proteomics analysis
Purpose We used proteomic sequencing and experimental verification to identify the potential ferroptosis-related proteins in ameloblastoma. Methods Samples of ameloblastoma (n = 14) and normal gingival tissues (n = 5) were collected for proteomic sequencing to identify differentially expressed proteins (DEPs) in ameloblastoma. Ferroptosis-related genes were downloaded from FerrDb V2, which were then compared with DEPs to obtain ferroptosis-related DEPs (FR-DEPs). A functional enrichment analysis was performed, and a protein–protein interaction network was built. The hub proteins were screened using the Cytoscape software, and potential drugs targeting them were retrieved from the DrugBank database. A hub protein was selected for immunohistochemical validation, and its expression was assessed in ameloblastomas, odontogenic keratocysts, dentigerous cysts, and normal gingival tissues. The primary ameloblastoma cells were cultured to explore the effect of the protein on the migratory properties of the tumour cells. Results A total of 58 FR-DEPs were screened, and six hub proteins were identified: mTOR, NFE2L2, PRKCA, STAT3, EGFR, and CDH1. Immunohistochemical analysis showed that mTOR expression was upregulated in ameloblastomas compared with that in odontogenic keratocysts, dentigerous cysts, and normal gingival tissues. p-mTOR was highly expressed in ameloblastomas, with a positivity rate of 83.3%. In addition, rapamycin, an inhibitor of mTOR, can inhibit the migratory capacity of primary cultured ameloblastoma cells. Conclusion Our results revealed the ferroptosis-related proteins in ameloblastomas and their underlying biological processes. Additionally, mTOR was overexpressed and was found to be associated with the aggressiveness of ameloblastomas, which may be a potential target for future treatments.